2017-12-06 14:38:26 UTC

Call on Congress to Increase NIH Funding

Dec. 7, 2017

AGA supports a $2 billion increase to support federal research funding.

Congress is expected to pass a short-term continuing resolution (CR) to fund the government until Dec. 22 before the current one expires on Dec. 8. Congressional leaders contend that the short-term CR will give them time to negotiate a longer-term spending bill that may address budget spending caps on discretionary and military spending. 

As House and Senate leaders continue to negotiate spending packages, it is critical that Congress continue to hear the importance of increasing funding for NIH. This year, both the House and Senate Appropriations Committees made recommendations for a $2 billion increase to NIH, which AGA and the entire research community supports. NIH has received bipartisan and bicameral support, but with all the competing interests that mount toward the end of the year, it is critical that Congress hears from their constituents on the importance of funding NIH and the economic growth that it generates in addition to advancing health care in our country.

Please take a moment and contact your legislators. AGA continues to advocate for increases to NIH funding for digestive disease research and will monitor the budget process.

More on Research Funding

2018 Research Grants Open for Applications

Dec. 11, 2017

Don't lose sight of award deadlines during the busy holiday season. Read on to discover open grants from the AGA Research Foundation and when applications are due.

Research Scholar Award (RSA)

Nov. 30, 2017

(Currently Closed: All details within apply to the 2018 grant and are subject to change. Details for the 2019 grant will be available May 2018.) This award provides $90,000 per year for three years (total $270,000) to a young investigator, instructor, research associate or equivalent working toward an independent career in gastroenterology, hepatology or related areas.

Litwin IBD Pioneers Initiative

Nov. 27, 2017

Funding available for innovative clinical and translational research projects with the potential to improve the treatment of inflammatory bowel disease (IBD).